BioScrip reports loss in revenues

Friday, May 6, 2016

DENVER – BioScrip reported net revenues of $238.5 million for the first quarter of 2016, compared to $244.4 million for the same period a year ago, a decrease of 2.4%. Adjusted EBITDA was $7.4 millionvs. $4.9 million. The company said it was “pleased” with results and that the decrease in revenue stems from a planned shift in revenue mix away from lower margin chronic infusion revenue to its core infusion business